Pfizer cancer drug trial halted early after only 9 patients
NCT ID NCT06285097
First seen Nov 01, 2025 · Last updated Apr 25, 2026 · Updated 29 times
Summary
This early-stage study tested a new experimental drug (PF-07820435) alone or with another drug (sasanlimab) in people with advanced solid tumors like lung, skin, and kidney cancers. The goal was to check safety and find the right dose. Only 9 people took part before the study was stopped early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Corewell Health (reference non-engagement letter)
Grand Rapids, Michigan, 49503, United States
-
Florida Cancer Specialists Sarasota Drug Development Unit
Sarasota, Florida, 34232, United States
-
Hospital Oncologico Dr. Isaac Gonzalez-Martinez
Rio Piedras, 00935, Puerto Rico
-
National Cancer Center Hospital East
Kashiwa, Chiba, 277-8577, Japan
-
Pan American Center for Oncology Trials, LLC
Rio Piedras, 00935, Puerto Rico
-
SCRI Oncology Partners
Nashville, Tennessee, 37203, United States
-
START Midwest
Grand Rapids, Michigan, 49546, United States
-
Sarah Cannon Research Institute - Pharmacy
Nashville, Tennessee, 37203, United States
-
The Cancer Institute Hospital of JFCR
Koto, Tokyo, 135-8550, Japan
-
Tristar Centennial Medical Center
Nashville, Tennessee, 37203, United States
Conditions
Explore the condition pages connected to this study.